NASDAQ:NVAX

Novavax Stock Predictions

etoro logo Buy NVAX
*Your capital is at risk
$10.20
-0.0100 (-0.0979%)
At Close: Jun 03, 2026
Currently predicting for Fri, 5 Jun 2026

NVAX Prediction Chart

NVAX Predictions History

Latest community submissions for NVAX.
Predictor Target Session Target Price Result Direction Accuracy Score
jjsheets330 jjsheets330 Merchant @jjsheets330.186247
Mar 23, 2021 $307.00 +39.65% $219.84 X 60.35% 0
JS JS Pro
Mar 23, 2021 $242.79 +10.44% $219.84 X 89.56% 0
Mar 23, 2021 Bullish $219.84 X 0
JS JS Pro
Mar 17, 2021 $218.99 -2.87% $225.46 X 97.13% 0
Mar 17, 2021 $230.00 +2.01% $225.46 X 97.99% 1
jjsheets330 jjsheets330 Merchant @jjsheets330.186247
Mar 15, 2021 $307.00 +41.18% $217.46 X 58.82% 1
Mar 15, 2021 $230.00 +5.77% $217.46 X 94.23% 1
JS JS Pro
Mar 12, 2021 $200.48 -1.13% $202.77 X 98.87% 2
SHAMOO SHAMOO Amateur
Mar 12, 2021 Bullish $202.77 X 1
Moe A Moe A @MoeA.168788
Mar 12, 2021 $237.50 +17.13% $202.77 X 82.87% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for NVAX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT NOVAVAX INC
Novavax
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical tria...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE